SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-10-004365
Filing Date
2010-12-09
Accepted
2010-12-09 16:10:49
Documents
4
Period of Report
2010-10-31

Document Format Files

Seq Description Document Type Size
1 PEREGRINE PHARMACEUTICALS, INC. peregrine_10q-103110.htm 10-Q 1072194
2 CERTIFICATION peregrine_10q-ex3101.htm EX-31.1 12573
3 CERTIFICATION peregrine_10q-ex3102.htm EX-31.2 12521
4 CERTIFICATION peregrine_10q-ex32.htm EX-32 11885
  Complete submission text file 0001019687-10-004365.txt   1110841
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-32839 | Film No.: 101242502
SIC: 2835 In Vitro & In Vivo Diagnostic Substances